Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. EBITDA 2016–2025
Dianthus Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2016 to 2020. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Dianthus Therapeutics Inc. ebitda for the quarter ending March 31, 2020 was -20.8 M, a 30.29% increase year-over-year.
- Dianthus Therapeutics Inc. annual ebitda for 2019 was -81.1 M, a 37.30% increase from 2018.
- Dianthus Therapeutics Inc. annual ebitda for 2018 was -59.1 M, a 67.15% increase from 2017.
- Dianthus Therapeutics Inc. annual ebitda for 2017 was -35.4 M, a 281.68% increase from 2016.
- Dianthus Therapeutics Inc. annual ebitda for 2016 was -9.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Dianthus Therapeutics Inc. EBITDA — FAQ
Dianthus Therapeutics Inc. (DNTH) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNTH's ebitda history?
The chart and table above show Dianthus Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.